Implication of α1-antichymotrypsin polymorphism in familial Alzheimer's disease

Neuroscience Letters

Volumn 244, Issue 2, 1998, Pages 85-88

  Nacmias, Benedetta ^a   Marcon, Gabriella ^b   Tedde, Andrea ^a   Forleo, Paolo ^a   Latorraca, Stefania ^a   Piacentini, Silvia ^a   Amaducci, Luigi ^a   Sorbi, Sandro ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF UDINE   (Italy)

Author keywords

1 Antichymotrypsin; Alzheimer's disease; Apolipoprotein E; Genetics; Polymorphism

Indexed keywords

ALPHA 1 ANTICHYMOTRYPSIN; PRESENILIN 1; AMYLOID BETA PROTEIN; APOLIPOPROTEIN E; APOLIPOPROTEIN E4; MEMBRANE PROTEIN; PSEN1 PROTEIN, HUMAN;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; DNA POLYMORPHISM; GENE MUTATION; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; HUMAN; MAJOR CLINICAL STUDY; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; ALLELE; DISEASE PREDISPOSITION; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; MIDDLE AGED; ONSET AGE; REFERENCE VALUE; RISK FACTOR;

ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; ALLELES; ALPHA 1-ANTICHYMOTRYPSIN; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; DISEASE SUSCEPTIBILITY; GENE FREQUENCY; GENOTYPE; HUMANS; MEMBRANE PROTEINS; MIDDLE AGED; POLYMORPHISM, GENETIC; PRESENILIN-1; REFERENCE VALUES; RISK FACTORS;

EID: 0032512989     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(98)00134-7     Document Type: Article

References (17)

1. Corder E.H., Saunders A.M., Strittmatter W.J., Schmechel D.E., Gaskel P.C., Small G.W., Roses A.D., Haines J.L., Pericak-Vance M.A. Gene dose of Apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science. 261:1993;921-923.
2. Haines J.L., Pritchard M.L., Saunders A.M., Schildkraust J.M., Growdon J.H., Gaskell P.C., Farrer L.A., Auerbach S.A., Gusella J.F., Locke P.A., Rosi B.L., Yamaoka L., Small G.W., Conneally P.M., Roses A.D., Pericak-Vance M.A. No genetic effect of α1-antichymotrypsin in Alzheimer disease. Genomics. 33:1996;53-56.
3. Helisalmi S., Mannermaa A., Lehtovirta M., Ryynanen M., Riekkinen P. Sr., Soininen H. No association between α1-antichymotrypsin polymorphism, Apolipoprotein E and patients with late-onset Alzheimer's disease. Neurosci. Lett. 231:1997;56-58.
4. Kamboh M.I., Sanghera D.K., Ferrel R.E., DeKoski S.T. ApoE*4-associated Alzheimer's disease risk is modified by α1-antichymotrypsin polymorphism. Nat. Genet. 10:1995;486-488.
5. Lendon C.L., Ashall F., Goate A. Exploring the etiology of Alzheimer disease using molecular genetics. J. Am. Med. Assoc. 277:1997;825-831.
6. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 34:1984;939-944.
7. Miller S.A., Dykes D.D., Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acid Res. 16:1988;1215.
8. Muller U., Bodeker R.-H., Gerundt I., Kurz A. Lack of association between α1-antichymotrypsin polymorphism, Alzheimer's disease, and allele ε4 of Apolipoprotein E. Neurology. 47:1996;1575-1577.
9. Nacmias B., Latorraca S., Piersanti P., Forleo P., Piacentini S., Bracco L., Amaducci L., Sorbi S. ApoE genotype and familial Alzheimer's disease: a possible influence on age of onset in APP717 Val→Ile mutated families. Neurosci. Lett. 183:1995;1-3.
10. Nacmias B., Tedde A., Latorraca S., Piacentini S., Bracco L., Amaducci L., Guarnieri B.M., Petruzzi C., Ortenzi L., Sorbi S. Apolipoprotein E and α1-antichymotrypsin polymorphism in Alzheimer's disease. Ann. Neurol. 40:1996;678-680.
11. Pericak-Vance M.A., Bass M.P., Yamaoka L.H., Gaskell P.C., Scott W.K., Terwedow H.A., Menold M.M., Conneally P.M., Small G.W., Vance J.M., Saunders A.M., Roses A.D., Haines J.L. Complete genomic screen in late-onset familial Alzheimer disease. Evidence for a new locus on chromosome 12. J. Am. Med. Assoc. 278:1997;1237-1241.
12. Rogaev E.I., Sherrington R., Rogaeva E.A., Levesque G., Ikeda M., Liang Y., Chi H., Lin C., Holman K., Tsuda T., Mar L., Sorbi S., Nacmias B., Piacentini S., Amaducci L., Chumakov I., Cohen D., Lannfelt L., Fraser P.E., Rommens J.M., St. George-Hyslop P.H. Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature. 376:1995;775-778.
13. Sorbi S., Nacmias B., Forleo P., Latorraca S., Gobbini I., Bracco L., Piacentini S., Amaducci L. ApoE allele frequencies in Italian sporadic and familial Alzheimer's disease. Neurosci. Lett. 177:1994;100-102.
14. Sorbi S., Nacmias B., Forleo P., Piacentini S., Amaducci L., Provinciali L. APP717 and Alzheimer's disease in Italy. Nat. Genet. 4:1993;10.
15. Sorbi S., Nacmias B., Forleo P., Piacentini S., Sherrington R., Rogaev E., St. George-Hyslop P.H., Amaducci L. Missense mutation of S182 gene in families with early onset Alzheimer's disease. Lancet. 346:1995;439-440.
16. Talbot C., Houlden H., Craddock N., Crook R., Hutton M., Lendon C., Prihar G., Morris J.C., Hardy J., Goate A. Polymorphism in AACT gene may lower age of onset of Alzheimer's disease. NeuroReport. 7:1996;534-536.
17. Van Duijn C.M., De Kniuff P., Cruts M., Wehnert A., Havekes L.M., Hofman A., Van Broeckhoven C. Apolipoprotein E4 allele in a population-based study of early-onset Alzheimer's disease. Nat. Genet. 7:1994;74-77.